New stitch could slash hernia risk in cancer patients after major abdominal surgery

NCT ID NCT07218679

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study compares two types of stitches used to close large abdominal incisions in cancer patients. One is a special barbed suture called Stratafix, and the other is a standard resorbable stitch. The goal is to see if Stratafix reduces the chance of developing an incisional hernia, a common complication after surgery. The trial involves 140 adults undergoing surgery for tumors in the abdomen or for cancer spread in the belly lining.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Stratafix suture (a barbed, coated stitch) and PDS Plus suture (a resorbable monofilament stitch)

What this could lead to

If it works, this could point toward a better way to close large abdominal incisions in cancer patients, reducing the risk of painful hernias after surgery.

What could go wrong

This is a relatively small, early-stage trial with 140 participants, so results may not apply to all patients. The study is not yet recruiting, and the intervention is a device, not a drug, so benefits may be modest.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INCISIONAL HERNIA AFTER MIDLINE LAPAROTOMY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

retroperitoneal neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Hospital Universitario Virgen del Rocio

    Seville, 41013, Spain